- Tytuł:
- EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky.
- Autorzy:
- Źródło:
- PloS one [PLoS One] 2020 Aug 18; Vol. 15 (8), pp. e0237790. Date of Electronic Publication: 2020 Aug 18 (Print Publication: 2020).
- Typ publikacji:
- Journal Article; Research Support, N.I.H., Extramural
- MeSH Terms:
-
Carcinoma, Non-Small-Cell Lung/*drug therapy
Erlotinib Hydrochloride/*therapeutic use
Genetic Testing/*statistics & numerical data
Lung Neoplasms/*drug therapy
Administrative Claims, Healthcare/statistics & numerical data ; Adult ; Age Factors ; Aged ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; DNA Mutational Analysis/economics ; DNA Mutational Analysis/statistics & numerical data ; Drug Prescriptions/economics ; Drug Prescriptions/statistics & numerical data ; Drug Utilization/economics ; Drug Utilization/statistics & numerical data ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Female ; Genetic Testing/economics ; Healthcare Disparities/economics ; Humans ; Kentucky/epidemiology ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Male ; Medicaid/economics ; Medicaid/statistics & numerical data ; Medicare/economics ; Medicare/statistics & numerical data ; Middle Aged ; Mutation ; Poverty/statistics & numerical data ; Precision Medicine/economics ; Precision Medicine/statistics & numerical data ; Registries/statistics & numerical data ; Retrospective Studies ; Sex Factors ; Survival Analysis ; United States ; Young Adult
Czasopismo naukowe